2016 American Transplant Congress
Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.
The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior compared to CellCept®, (mycophenolate…2016 American Transplant Congress
Endoscopic Polydimethylsiloxane Injection in Prevention of Recurrent Graft Pyelonephritis for Transplanted Kidney with Vesicoureteral Reflux.
Reccurent acute graft pyelonephritis (AGPN) with vesicoureteral reflux (GVUR) can have a deleterious impact on graft outcome. The objective of this study was to evaluate…2016 American Transplant Congress
Serum Albumin Level Has Association with Both Graft Failure and Mortality in Kidney Transplant Recipients.
Background: The studies concerned the association between post-transplant serum albumin concentration and post-transplant outcomes in kidney transplant recipients (KTRs) are scarce.Methods: To evaluate the impact…2016 American Transplant Congress
Association Between GFR Decline and Long Term Outcome in Renal Transplantation.
1Nephrology Department, CHU, Saint Etienne, France; 2Nephrology Department, CHU, Nimes, France.
In renal transplantation, GFR decline is strongly associated to graft failure and patient death and thus could be an interesting proxy for clinical research. GFR…2016 American Transplant Congress
Treg-Rich Organized Lymphoid Structures (TOLS) in Spontaneously Accepted Mouse Kidney Allografts.
Background: In many MHC mismatched strain combinations (e.g., DBA/2 to B6) kidney allografts are spontaneously accepted without immunosuppression. This tolerance is regulatory, initially dependent Foxp3+…2016 American Transplant Congress
Donor Smoking Increases Kidney Allograft Recipient Mortality in a National Population Cohort Analysis.
Introduction: Current evidence from single-centre analyses suggest cigarette smoking in living donors is associated with worse patient but not graft survival in kidney allograft recipients.…2016 American Transplant Congress
Comparison of Transplant Outcomes for Low-Dose and Standard-Dose Tacrolimus in Kidney Transplant Recipients.
Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
Objectives: There are few studies that compare the effect of different dose of tacrolimus after kidney transplantation. We investigated transplant outcome of low-dose and standard-dose…2016 American Transplant Congress
Risk Factors for Hospitalization Among Waitlisted End Stage Renal Disease Patients.
Background: For End Stage Renal Disease Patients (ESRD) waitlisted for a deceased donor kidney, hospitalization is associated with lower likelihood of transplantation and worse outcomes.…2016 American Transplant Congress
Hospitalizations for Cardiovascular Disease After Kidney Transplantation: The Role of Facility Characteristics on Outcomes and Costs.
Background: Long term outcomes are in jeopardy when kidney transplant recipients are hospitalized with cardiovascular disease (CVD). We sought to understand hospital predictors of inpatient…2016 American Transplant Congress
Tocilizumab as Treatment for Persistent Chronic Active Antibody Mediated Rejection.
Columbia University Medical Center, NYC.
Intro: CAAMR is an increasingly recognized cause of renal allograft failure with limited treatment options. Many patients with CAAMR have engagement of both T and…
- « Previous Page
- 1
- …
- 429
- 430
- 431
- 432
- 433
- …
- 531
- Next Page »